Effect of Subcutaneous Spesolimab on the Prevention of Generalized Pustular Psoriasis Flares Over 48 weeks: Subgroup Analyses from the Effisayil 2 Trial . J of Skin. 2023;7(6):s245. doi:10.25251/skin.7.supp.245